Form D · Other Technology

PerceptiMed, Inc.

Mountain View, CA · CIK 0001563500

Offering snapshot reported Oct 12, 2018 · SEC filing

Reported sold
$2.07M
Offering amount: $4M
Investors reported
5
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Sep 27, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 12, 2018Initial$2,067,056No comparison5SEC filing
Mar 26, 2015Amendment$5,352,237$2,959,619vs Sep 19, 20148SEC filing
Sep 19, 2014Initial$2,392,618No comparison4SEC filing
Sep 19, 2013Initial$499,999No comparison1SEC filing
Dec 4, 2012Initial$3,124,999No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-323387

Source: Form D, filed Oct 12, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Grace Colon Director, Executive
Robert E. Curry Director, Executive
John Friedman Director
Jennifer Jacobs Director
Alan Jacobs Executive
Tom King Director
Thomas Lavin Director
Frank Maione Executive
Rodney Markin Director
Hamutal Russo Executive
Robert Schueren Director
Somu Subramaniam Director
James Woody Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
365 San Antonio Road
Mountain View, CA, 94040